Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc8.5 | Neuroendocrinology | ECE2017

Ephrin-B2 is required for pituitary development

Jimenez Fernando , Gualtieri Angelica , Scagliotti Valeria , Gaston-Massuet Carles

The pituitary progenitors are responsible for generating a fully functional endocrine organ during embryonic development. They also preserve potency, to maintain the homoeostasis in the adult pituitary, being able to respond to endocrine challenges, such as pregnancy or obesity. But the main players of this complex process remain elusive. Eph-Ephrins have been implicated in an increasing number of physiological functions such as axon-guidance, eye field segregation from neural...

ea0086p361 | Reproductive Endocrinology | SFEBES2022

Genomic imprinting and maternal adaptations to pregnancy

Charalambous Marika , Scagliotti Valeria , Esse Ruben , Amarsi Risha , Lillina Vignola Maria

In late pregnancy the mother must mobilise considerable energy stores to support fetal growth. Failure to appropriately nourish the fetus has significant obstetric consequences – gestational diabetes and fetal growth restriction (FGR). Despite this, relatively little is known about how metabolic responses are stimulated in the mother, and how they may go wrong. We previously found that high levels of the product of an imprinted gene, Delta-like homologue-1 (D...

ea0051oc4.3 | Oral Communications 4 | BSPED2017

Novel FOXA2 mutation causes hyperinsulinism, hypopituitarism with craniofacial dysmorphism and endoderm-derived organ abnormalities

Giri Dinesh , Vignola Marial Lillina , Gualtieri Angelica , Scagliotti Valeria , McNamara Paul , Peak Matthew , Didi Mohammed , Gaston-Massuet Carles , Senniappan Senthil

Background: Congenital hypopituitarism (CH) is characterised by the deficiency of one or more pituitary hormones and can present alone or in association with complex disorders. Congenital hyperinsulinism (CHI) is a disorder of unregulated insulin secretion despite hypoglycaemia that can occur in isolation or as part of a syndrome. The underlying genetic etiology causing the complex phenotype of CH and CHI is unknown.Patient and Methods: A female baby bor...

ea0050oc5.6 | Reproduction and Neuroendocrinology | SFEBES2017

The MAPK effector B-Raf is essential for hypothalamic–pituitary axis development and activating mutations in BRAF cause congenital hypopituitarism

Kyprianou Nikolina , Gregory Louise , Lillina Vignola Maria , Besser Rachel , Marinelli Eugenia , Gualtieri Angelica , Scagliotti Valeria , Davis Shannon , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Somatic activating mutations in BRAF, encoding B-Raf, have been described in tumours and recently craniopharyngiomas. Germline mutations in BRAF and other components of the RAS/MAPK pathway are found in RASopathies, whose features include endocrine deficiencies but not craniopharyngiomas. We report three BRAF mutations (two of which are novel) in four children with congenital hypopituitarism. To demonstrate the functional role of the three variants w...

ea0050p273 | Neuroendocrinology and Pituitary | SFEBES2017

Cyclooxygenase-2 is a potential target for the treatment of Adamantinomatous craniopharyngioma

Scagliotti Valeria , Gutierrez Lorena Perez , Gualtieri Angelica , Jimenez Fernando , Kirkby Nicholas , Mitchell Jane , Warner Timothy , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Adamantinomatous craniopharyngiomas (ACPs) are among the most common intracranial tumours in children and they originate from undifferentiated pituitary progenitors. Mutations in the gene encoding for β-catenin (CTNNB1), which lead to the constitutive activation of the Wnt/β-catenin signalling pathway, have been associated with ACP. These tumours can invade adjacent structures, such as the hypothalamus, which makes comp...

ea0050oc5.6 | Reproduction and Neuroendocrinology | SFEBES2017

The MAPK effector B-Raf is essential for hypothalamic–pituitary axis development and activating mutations in BRAF cause congenital hypopituitarism

Kyprianou Nikolina , Gregory Louise , Lillina Vignola Maria , Besser Rachel , Marinelli Eugenia , Gualtieri Angelica , Scagliotti Valeria , Davis Shannon , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Somatic activating mutations in BRAF, encoding B-Raf, have been described in tumours and recently craniopharyngiomas. Germline mutations in BRAF and other components of the RAS/MAPK pathway are found in RASopathies, whose features include endocrine deficiencies but not craniopharyngiomas. We report three BRAF mutations (two of which are novel) in four children with congenital hypopituitarism. To demonstrate the functional role of the three variants w...

ea0050p273 | Neuroendocrinology and Pituitary | SFEBES2017

Cyclooxygenase-2 is a potential target for the treatment of Adamantinomatous craniopharyngioma

Scagliotti Valeria , Gutierrez Lorena Perez , Gualtieri Angelica , Jimenez Fernando , Kirkby Nicholas , Mitchell Jane , Warner Timothy , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Adamantinomatous craniopharyngiomas (ACPs) are among the most common intracranial tumours in children and they originate from undifferentiated pituitary progenitors. Mutations in the gene encoding for β-catenin (CTNNB1), which lead to the constitutive activation of the Wnt/β-catenin signalling pathway, have been associated with ACP. These tumours can invade adjacent structures, such as the hypothalamus, which makes comp...

ea0051oc4.4 | Oral Communications 4 | BSPED2017

The MAPK effector B-Raf is essential for hypothalamic-pituitary axis development and activating mutations in BRAF cause congenital hypopituitarism

Kyprianou Nikolina , Gregory Louise , Vignola Maria Lillina , Nichols James , Marinelli Eugenia , Gualtieri Angelica , Scagliotti Valeria , Besser Rachel , Camper Sally , Davis Shannon , Hogler Wolfgang , Temple Karen , Davies Justin H , Casado Pedro , Rajeeve Vinothini , Cutillas Pedro , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Germline mutations in BRAF and other components of the RAS/MAPK pathway are found in RASopathies, whose features include short stature and pubertal delay. The underlying mechanism of endocrinopathies in RASopathies has not been fully elucidated. We report four BRAF mutations (two of which are novel) in four children with congenital hypopituitarism and RASopathy features. To demonstrate the functional role of the variants we performed phosphoproteomic analyses...